You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
印度疫情惡化 港A兩地抗疫概念股全線上漲 A股現漲停潮
格隆匯 04-26 10:42
格隆匯4月26日丨港股開拓藥業漲超13%,康希諾生物漲超8%,四環醫藥漲超7%,山東新華製藥、復星醫藥等均明顯走強;A股四環生物、美諾華、常見健康、明德生物等多股漲停。印度正在遭遇疫情“全面失控”、醫療系統接近崩潰的危險。最近三天印度新冠確診超過了100萬,累計報吿新冠肺炎確診病例1696萬例,僅次於美國,單日新增創紀錄的2767例新冠肺炎死亡病例。印度政府25日預測,該國這一波新冠疫情可能於5月中旬達到峯值,屆時每天新增確診病例將高達50萬例。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account